Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 1,818 citations
https://doi.org/10.1016/s0140-6736(21)00676-0
R
Ravi Kumar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
840
Citations
3
h-index
2
i10-index
Ravi Kumar is an academic researcher from Institute of Medical Sciences. The author has contributed to research in topics: Tuberculosis Research and Epidemiology & Child Nutrition and Water Access & Global Maternal and Child Health. The author has an h-index of 3, co-authored 7 publications.
Papers by this author
worksGlobal, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 · The Lancet · 1,663 citations
https://doi.org/10.1016/s0140-6736(14)60696-6
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 · The Lancet · 990 citations
https://doi.org/10.1016/s0140-6736(14)60844-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat